Recombinant Human ABHD18 Protein ，His & SUMO

ABHD18 (Alpha/Betahydrolase Domain Containing 18) is a member of the alpha/beta hydrolase superfamily, which is known for its roles in lipid metabolism and signaling pathways. Understanding ABHD18 is increasingly important due to its potential implications in various health disorders, including metabolic diseases and neurodegenerative conditions. Research has revealed that ABHD18 may influence the regulation of bioactive lipids, such as endocannabinoids and fatty acids, thereby playing a crucial role in cellular signaling and homeostasis. The recombinant expression of ABHD18 in heterologous systems enables researchers to investigate its enzymatic activity, substrate specificity, and interaction with regulatory proteins. Additionally, studying ABHD18 can provide insights into its structure-function relationship and its role in modulating physiological processes. The characterization of ABHD18 through recombinant protein techniques could unveil new therapeutic targets for drug development, particularly in conditions where lipid dysregulation is a key factor. Moreover, given the emerging evidence linking ABHD18 to inflammatory responses and neuroprotective mechanisms, further research could contribute to the understanding of its role in maintaining cellular health and its potential as a novel biomarker in disease contexts. Overall, the investigation of ABHD18 recombinant protein holds promise for advancing our knowledge of lipid biology and its associated implications in health and disease.